QGEN

Qiagen NV
D

QGEN

42.660
USD
-1.19
(-2.71%)
مغلق
حجم التداول
126,341
الربح لكل سهم
3
العائد الربحي
0.8
P/E
22
حجم السوق
8,809,076,700
أصول ذات صلة المقالات
المزيد

العنوان: Qiagen NV

القطاع: الرعاية الصحية
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).